MyFinsight
Home
Blog
About
Contact
Download
Download image
Auryxia
$181,542K
Vafseo
$45,790K
Japan Tobacco
Incorporation And Torii...
$5,659K
Mitsubishi Tanabe Pharma
Corporation
$2,794K
MEDICEArzneimittel Putter Gmb HCo KG
$411K
Comprehensive loss
-$5,345K
Product
$227,332K
License Collaboration
And Other Revenue
$8,864K
Net loss
-$5,345K
Total revenues
$236,196K
Loss before income
taxes
-$3,721K
Income tax expense
$1,624K
Income (loss) from
operations
$23,499K
Other income
$58K
Total operating
expenses
$173,235K
Total cost of goods
sold
$39,462K
Interest expense
-$24,179K
Change in fair value of
warrant liability
$3,099K
Selling, general and
administrative
$107,480K
Research and development
$62,359K
License
$3,396K
Cost of product and
other revenue
$39,462K
Back
Back
Income Statement
source: myfinsight.com
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA)